Rossari Biotech IPO GMP History
Rossari Biotech IPO has been listed on July 23, 2020 at a listing price of ₹669.25, against the issue price of ₹425 — a gain of ₹244.25 (+57.47%). The GMP peaked at ₹177.5 on 22 July 2020 and reached a low of ₹37.5 on 7 July 2020. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Rossari Biotech IPO raised ₹496.25 Cr. through its IPO at a price band of ₹423 to ₹425 per share, with a lot size of 35 shares. The IPO was open for subscription from 13 Jul 2020 to 15 Jul 2020.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 11 Nov, 6:58 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 22 Jul 2020 | ₹ 177.5 | ▲ | 42% | — | — |
| 21 Jul 2020 | ₹ 162.5 | — | 38% | — | — |
| 20 Jul 2020 | ₹ 162.5 | ▲ | 38% | — | — |
| 19 Jul 2020 | ₹ 157.5 | — | 37% | — | — |
| 18 Jul 2020 | ₹ 157.5 | — | 37% | — | — |
| 17 Jul 2020 | ₹ 157.5 | ▲ | 37% | — | — |
| 16 Jul 2020 | ₹ 147.5 | ▲ | 35% | — | — |
| 15 Jul 2020 | ₹ 127.5 | — | 30% | — | — |
| 14 Jul 2020 | ₹ 127.5 | ▼ | 30% | — | — |
| 13 Jul 2020 | ₹ 147.5 | ▲ | 35% | — | — |
| 12 Jul 2020 | ₹ 127.5 | — | 30% | — | — |
| 11 Jul 2020 | ₹ 127.5 | — | 30% | — | — |
| 10 Jul 2020 | ₹ 127.5 | — | 30% | — | — |
| 09 Jul 2020 | ₹ 127.5 | ▲ | 30% | — | — |
| 08 Jul 2020 | ₹ 97.5 | ▲ | 23% | — | — |
| 07 Jul 2020 | ₹ 37.5 | — | 9% | — | — |
| 06 Jul 2020 | ₹ 37.5 | — | 9% | — | — |
Rossari Biotech IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 13 Jul 2020
- Close 15 Jul 2020
- Allotment 20 Jul 2020
- Refund/credit 21 Jul 2020
- Listing 23 Jul 2020
Rossari Biotech IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹425 |
|---|---|
| GMP-based estimate (pre-listing) | ₹602 (+41.6%) |
| Listing gain / loss | +₹244.25 per share |
| Listing date | 23 Jul, 2020 |
| Actual listing price | ₹669.25 (+57.47%) |
Is Rossari Biotech IPO GMP reliable?
Grey market premium for Rossari Biotech IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Rossari Biotech IPO full review for a fundamentals-based assessment before making any grey market trades.
Rossari Biotech IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Rossari Biotech IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Rossari Biotech IPO
Rossari Biotech Limited was founded in 2009 by its promoters, Edward Menezes and Sunil Chari. They started the business in 2003 as a partnership firm called Rossari Labtech.
It sells home, personal care and performance chemicals, textile specialty chemicals, and animal health and nutrition products. According to the F&S Report in its RHP, it was the largest manufacturer of textile specialty chemicals in India as on 30 September 2019.
It operates in India and 17 foreign countries, including Vietnam, Bangladesh and Mauritius. Its Silvassa plant has an installed capacity of 100,000 MTPA, and it was setting up a plant at Dahej with 132,500 MTPA.
The IPO was Rs 496.25 crore, with Rs 50.00 crore of fresh issue and Rs 446.25 crore of offer for sale by the two promoters. The fresh money, together with a pre-IPO placement, was mainly planned for repaying debt and funding working capital.
Frequently asked
What is the GMP of Rossari Biotech IPO?
The current Grey Market Premium (GMP) of Rossari Biotech IPO is ₹ 177.5.
What is the Kostak Price of Rossari Biotech IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Rossari Biotech IPO is not available.
What is the Subject to Sauda Price of Rossari Biotech IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Rossari Biotech IPO?
Rossari Biotech IPO listed on July 23, 2020 at ₹669.25, against the issue price of ₹425 — a gain of +57.47%.
How did the GMP of Rossari Biotech IPO trend before listing?
The GMP of Rossari Biotech IPO was rising in its final days before listing. The GMP peaked at ₹177.5 on 22 July 2020. View the day-wise table above for the complete GMP history.
Explore Rossari Biotech IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
